Denise Scots-Knight
2022
In 2022, Denise Scots-Knight earned a total compensation of $2.2M as Chief Executive Officer at Mereo BioPharma Group plc.
Compensation breakdown
| Bonus | $304,085 |
|---|---|
| Option Awards | $1,358,134 |
| Salary | $506,809 |
| Other | $68,219 |
| Total | $2,237,247 |
Scots-Knight received $1.4M in option awards, accounting for 61% of the total pay in 2022.
Scots-Knight also received $304.1K in bonus, $506.8K in salary and $68.2K in other compensation.
Rankings
In 2022, Denise Scots-Knight's compensation ranked 1,611th out of 5,760 executives tracked by ExecPay. In other words, Scots-Knight earned more than 72.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,611 out of 5,760 | 72nd |
Division Manufacturing | 827 out of 3,136 | 74th |
Major group Chemicals And Allied Products | 324 out of 1,422 | 77th |
Industry group Drugs | 301 out of 1,323 | 77th |
Industry Pharmaceutical Preparations | 215 out of 969 | 78th |
Source: SEC filing on April 24, 2024.
Scots-Knight's colleagues
We found two more compensation records of executives who worked with Denise Scots-Knight at Mereo BioPharma Group plc in 2022.